drugset / Trial / NCT02376036
Phase 1 Study of MGD010 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindBasic science
Summary
The primary goal of this Phase 1 study is to assess the safety and tolerability of one MGD010 intravenous (IV) infusion in healthy adult volunteers.
Timeline
- Start
- 2015-02
- Primary completion
- 2017-02
- Completion
- 2017-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Havrix | Vaccine | — | Intramuscular |
| Subject | MGD010 | Unknown | — | Intravenous |
Indications
No indication recorded.